Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy

Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy

Abstract Background 161Tb is an interesting radionuclide for cancer treatment, showing similar decay characteristics and chemical behavior to clinically-employed 177Lu. The therapeutic effect of 161Tb, however, may be enhanced due to the co-emission of a larger number of conversion and Auger electro...

Full description

Bibliographic Details
Main Authors: Nadezda Gracheva, Cristina Müller, Zeynep Talip, Stephan Heinitz, Ulli Köster, Jan Rijn Zeevaart, Alexander Vögele, Roger Schibli, Nicholas P. van der Meulen
Format: Article
Language:English
Published: SpringerOpen 2019-07-01
Series:EJNMMI Radiopharmacy and Chemistry
Subjects:
161Tb
Auger/conversion electrons
Purification method
Somatostatin analogues
DOTA
Online Access:http://link.springer.com/article/10.1186/s41181-019-0063-6

Internet

http://link.springer.com/article/10.1186/s41181-019-0063-6

Similar Items